Tom Hochuli

Chief Executive Officer

Tom Hochuli joined Vibalogics as CEO in 2020 and leads Vibalogics’ global organization. With more than 25 years of experience in the biopharma industry and has a proven track record in establishing and growing successful and thriving commercial-scale cell and gene therapy manufacturing facilities.
Before joining Vibalogics, Tom was Head of Cell and Gene Therapy Operations and Site Head of Lonza’s Houston facility, the world’s largest dedicated cell and gene therapy manufacturing facility covering 300,000 sq. ft.

Under his leadership, the site went from greenfield-to-GMP ready in just six months, doubled revenue every year for two consecutive years and increased headcount from 150 to 500 employees over the same period. While at Lonza, Tom was directly responsible for overseeing more than 40 cell and gene therapy client relationships, including early-phase, late-phase, and commercial manufacturing.